Biotechnology Stocks I Performance Guide: Vertex Pharmaceuticals Incorporated (VRTX)
VRTX has no dividends.
Table and Chart of VRTX Performance
See what a $1,000 investment in VRTX is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| VRTX Returns | |
|---|---|
| Start Date | May-30-2014 |
| Start Price | $72.26 |
| End Date | May-10-2024 |
| End Price | $422.78 |
| # Prices | 121 |
| Min Date | May-30-2014 |
| Min Price | $72.26 |
| Max Date | Jan-31-2024 |
| Max Price | $433.38 |
| Total Return | 485.08% |
| Annualized Return | 19.15% |
| Current Value of $1,000 Purchase | $5,851 |
| Number Returns | 7,260 |
| Average Return | 81.63% |
| Number Profitable Returns | 6,472 |
| Percent Profitable Returns | 89.15% |
| Number Unprofitable Returns | 788 |
| Percent Unprofitable Returns | 10.85% |
| Profitable to Unprofitable Returns Ratio | 8.21 |
| VRTX Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $108,121,620,000 |
| Beta | 0.387 | Price to Sales | 10.38 |
| Earnings per Share | $15.4200 |
| PE Ratio | 27.17 |
| PE to Growth Ratio | 0.534 |
| Price to Book | 5.83 |
| PRICE DATA | |
| 52 Week High | $448.4 |
| 52 Week Low | $320.01 |
| Analyst Target Price | $466.9 |
| 50-Day Moving Average | $407.88 |
| 200-Day Moving Average | $385.67 |
| FINANCIAL DATA | |
| Revenue per Share | $39.49 |
| Revenue | $10,185,000,000 |
| Profit Margin | 39.5% |
| Return on Equity | 24.4% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
VRTX Compare Returns with S&P 500
VRTX Trendline Chart
VRTX Moving Average Chart
VRTX Stock Return Map - See Patterns of Gains and Losses
VRTX Stock Returns/Purchase Dates